Dr Gilles DivitaFounder and CEO at DivincellSpeaker
Profile
Dr. Gilles DIVITA is founder and CEO of DIVINCELL (FR) and CSO of AANATRA LLC, California (USA). BioPharmaceutical NanoMedicine Start-up pioneering a novel drug delivery technology for the treatment of cancer and genetic diseases. Dr. DIVITA has over 25 years of experience in drug delivery systems, peptide-drugs and oligonucleotide therapeutics. He is the pioneer of the “non covalent cell penetrating peptide-based strategy” for therapeutic delivery and inventor of the peptide-based platform for RNA therapeutic strategy.
Agenda Sessions
PEP-NP : Peptide Based Nanoparticle-platform for Targeted Delivery of Functional RNAs
, 10:15View Session
